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Membrane permeabilizationTritrpticin is an antimicrobial peptidewith a strongmicrobicidal activity against Gram-positive and Gram-negative
bacteria as well as fungi. The 13-residue peptide is essentially symmetrical and possesses a unique cluster of
three Trp residues near the center of its amino acid sequence. The mechanism of action of tritrpticin is believed
to involve permeabilization of the cytoplasmicmembrane of susceptible bacteria. However it has been suggested
that intracellular targetsmay also play a role in its antimicrobial activity. In this work themechanism of action of
several tritrpticin derivatives was studied through substitution of the three Trp residues with 5-hydroxy-
tryptophan (5OHW), a naturally occurring non-ribosomal amino acid. Although it ismore polar, 5OHWpreserves
many of the biophysical and biochemical properties of Trp, allowing the use of ﬂuorescence spectroscopy and NMR
techniques to study the interaction of the modiﬁed peptides with membrane mimetics. Single or triple 5OHW
substitution did not have a large effect on the MIC of the parent peptide against Escherichia coli and Bacillus subtilis.
However, the mechanism of action was altered by simultaneously replacing all three Trp with 5OHW. Our results
suggest that the inner membrane of Gram-negative bacteria did not constitute the main target of this particular
tritrpticin derivative. Since the addition of a hydroxyl group to the indolemotif of the Trp residuewas able tomodify
themechanism of action of the peptides, our data conﬁrm the importance of the Trp cluster in tritrpticin. This work
also shows that 5OHW constitutes a new probe to modulate the antimicrobial activity and mechanism of action of
other Trp-rich antimicrobial peptides. This article is part of a Special Issue entitled: NMR Spectroscopy for Atomistic
Views of Biomembranes and Cell Surfaces. Guest Editors: Lynette Cegelski and David P. Weliky.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) have been the object of intense
research efforts during the past three decades [1–3]. As an integral
part of the innate immune systems of most living organisms (bacteria,
plants, insects and animals) AMPs have been identiﬁed as a promising
class of molecules with considerable therapeutic potential due to their
broad spectrum of activity against bacteria, fungi, parasites, viruseslar dichroism; COSY, correlation
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1 403 289 9311.and even cancer cells [4,5]. Currently more than 5000 antimicrobial
peptide sequences have been identiﬁed including naturally occurring
sequences, peptide analogs and predicted sequences [6,7]. However,
the original promise of a new family of antibiotics based on this type
of host-defense molecules has encountered several obstacles. Some of
these problems include the toxicity of AMPs towards eukaryotic cells,
the loss of activity at physiological pH and salt concentrations, as well
as their susceptibility to proteolytic degradation [4]. Initial attempts to
modulate the microbicidal activity of the peptides have focused on the
modiﬁcation of the amino acid sequence to enhance their antimicrobial
activity and improve their selectivity. Simultaneously themechanism of
action of AMPs has remained a fundamental question, which is impor-
tant in view of the fact that an understanding of this mechanism should
allow for the rational design of better and more speciﬁc microbicidal
agents [8,9]. Numerous studies have attempted to contribute to this
question. Most of the models generated agree on the importance of
the bacterialmembrane for the activity of thepeptides, not only because
it acts as the ﬁrst barrier that the peptide needs to overcome but also
because the membrane composition and properties can modulate their
activity [10,11]. Most of the AMPs have been described as membrane-
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permeabilization or disruption of the bacterial membrane. However the
presence of several AMPs without apparent membrane perturbing
effects, yet strong antimicrobial activities, generated proposals for
an alternative mechanism of action involving intracellular targets
such as DNA, RNA or proteins [12,13].
Tritrpticin is part of the cathelicidin family of AMPs; it has strong
antimicrobial activity against various bacteria and fungi [14]. This 13
amino acid peptide is part of the Arg (R)-Trp (W) rich family of AMPs
[15], due to its high content of Arg (30.8%) and Trp (23.1%) residues.
The sequence of tritrpticin (Table 1) is almost symmetrical and pos-
sesses an unusual hydrophobic core formed by three sequential W res-
idues. Tritrp1, the C-terminally amidated version of this peptide, has an
increased net positive charge (from +4 to +5), and this simple modi-
ﬁcation enhanced the antimicrobial activity of the peptide due to the
higher electrostatic attraction towards negatively charged bacterial
membranes surfaces [16]. Several tritrpticin and Tritrp1 analogs have
been developed and studied, showing the importance of residues such
as Pro, Arg and Trp in the antimicrobial activity [17–21]. Conservation
of the hydrophobic and aromatic character of the peptide's core is an
important determinant of the antimicrobial activity of this peptide
[16,18]. The mechanism of action of tritrpticin is believed to involve
pore formation in bacterial membranes. This notion is based on several
biophysical studies of the interaction of tritrpticin with model mem-
branes, as well as on membrane depolarization studies with Staphylo-
coccus aureus and Escherichia coli [18–20,22–25]. However
intracellular targets are also considered as part of tritrpticin's mecha-
nism of action [26].
Numerous studies of AMPs are focused on the engineering of new
peptide analogs that resemble the naturally occurring peptides, by
modiﬁcation of the original peptide sequences with natural amino
acids, D-amino acids, β-amino acids and other unnatural or non-
coded amino acids, see for example [27–32]. In this work Tritrp1
was modiﬁed through substitution of its Trp residues with 5-hydroxy-
tryptophan (5OHW). This naturally occurring amino acid is well
known as a metabolic intermediate in the biosynthesis of serotonin
and melatonin [33]. While 5OHW is not used in the ribosomal bio-
synthesis of proteins, it has been deployed in several studies as a
ﬂuorescence enhancement probe, due to its distinct ﬂuorescence
spectroscopic properties. 5OHW exhibits a red shifted absorbance
in comparison to Trp, by the presence of a shoulder at 310 nm. This
unique spectroscopic characteristic has allowed studies of several
protein–protein interactions, protein oligomerization states and confor-
mational changes, as well as investigations of the folding and stability
of proteins [34–36].
In the present study we determined whether 5OHW substitutions
inﬂuenced the antimicrobial activity of Tritrp1; the sequence of the
peptides studied are shown in Table 1. Secondly, we studied the mech-
anism of action of these Tritrp1 derivatives by ﬂuorescence, circular
dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy,
differential scanning calorimetry (DSC) and various other assays. Our
results revealed that the substitutions of individual or all three Trp res-
idues by 5OHW did not alter the antimicrobial activity of the peptide.
However the mechanism of action was signiﬁcantly changed when all
three Trp residues were substituted simultaneously.Table 1
Sequence of Tritrp1 and its derived peptides containing 5-hydroxy-
tryptophan (5OHW).
Peptide Sequence
Tritrp1 VRRFPWWWPFLRR-NH2
HW VRRFP5OHw5OHw5OHwPFLRR-NH2
HW1 VRRFP5OHwWWPFLRR-NH2
HW2 VRRFPW5OHwWPFLRR-NH2
HW3 VRRFPWW5OHwPFLRR-NH22. Materials and methods
2.1. Materials, bacterial strains and peptides
Nitroceﬁn (NCF) and 2-Nitrophenyl β-D-galactopyranoside (ONPG)
were obtained from EMD Millipore Corporation (Billerica, MA) and
Sigma-Aldrich (St. Louis, MO) respectively. [Methyl-3H]-thymidine
and [5-3H]-uridine were purchased from Perkin Elmer (Waltham,
MA), and [ring-2-5-3H]-L-histidine was obtained from Moravek Bio-
chemicals and Radiochemicals (Brea, CA). Sodium dodecyl sulfate
(SDS) was purchased from EMD Chemicals Inc. (Gibbstown, NJ) and
SDS-d25 was obtained from Cambridge Isotopes Laboratories (Andover,
MA). All other chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO).
All Tritrp1-derived peptideswere purchased fromAnaSpec Inc. (Fre-
mont, CA). The peptides were synthesized by solid phase methods and
their purity (N95%) and molecular weight were checked by HPLC and
mass spectrometry, respectively. Melittin, puriﬁed from honey bee
venom, was purchased from Sigma-Aldrich (St. Louis, MO).
E. coli ATCC 25922 was purchased from the American Type Culture
Collection (Manassas, VA). E. coli CGSC 4908 was obtained from the
E. coli genetic stock center (CGSC) at Yale University (New Haven, CT).
E. coliML35p andBacillus subtilis 168were kindly provided by Dr. Robert
Lehrer at UCLA David Geffen School of Medicine and Dr. Sui-LamWong
at University of Calgary, respectively.
2.2. Antibacterial activity
The antimicrobial activity of Tritrp1-derived peptides was measured
as theminimal inhibitory concentration (MIC) according to the standard
brothmicrodilutionmethod previously described byWiegand et al. [37].
Bacteria (E. coli ATCC 25922 and B. subtilis 168) were grown inMueller–
Hinton broth (MHB), whichwas incubated at 5 × 105 cfu/ml in the pres-
ence of two-fold dilutions of MHB-dissolved peptides (0.25 to 128 μM)
in a 96-well polypropylene plate, and incubated overnight at 37 °C.
The MIC values reported correspond to the minimal peptide concentra-
tion where bacterial growth was not observed. In order to establish the
minimal bactericidal concentration (MBC) 10 μl from the ﬁrst three
wells without bacteria growth for each peptide in theMIC platewere di-
luted 1:106 in MHB and plated (100 μl) in MHB-agar plates. After incu-
bation overnight at 37 °C the presence of colonies was established. The
MBC values reported correspond to the minimal peptide concentration
where no colony formation was detected.
2.3. Multilamellar vesicles (MLVs) and large unilamellar vesicles (LUVs)
preparation
MLVs were prepared by adding the necessary volume of DPPG or
DPPC-chloroform stock solutions (Avanti Polar Lipids, Alabaster, AL)
into a glass vial in order to have 0.5 mg of lipids. The organic solvent
was initially removed by evaporation in a stream of nitrogen gas and
the remaining solvent was evaporated under vacuum overnight. The
dry lipids were resuspended with warm Tris-buffer (10 mM Tris,
150mMNaCl, 1mMEDTA, pH 7.4) by vigorous vortexing. For DSC stud-
ies, Tritrp1-derived peptides in aqueous solution were added to the
MLVs suspension to achieve a peptide:lipid molar ratio of 1:10.
LUVs were made by initially preparingMLVs, as described previous-
ly, with the necessary volume of ePC, ePG or cholesterol–chloroform
stock solutions (Avanti Polar Lipids, Alabaster, AL) to obtain the desired
ratio. Two types of LUVs were prepared, ePC:ePG (1:1 molar ratio) and
ePC:cholesterol (2.5:1 molar ratio). The MLVs were freeze–thawed ﬁve
times using liquid nitrogen, followed by extrusion through two 0.1 μm
polycarbonate ﬁlters (Nucleopore Filtration Products, Pleasonton, CA)
using a mini-extruder apparatus (Avanti Polar Lipids, Alabaster, AL) to
generate LUVs with a 100 nm diameter. Calcein containing LUVs were
prepared by resuspending the dry lipids in Tris-buffer supplemented
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gel ﬁltration using a Sephadex G-50 column. The concentration of lipids
in the LUVs was measured by the Ames phosphate assay [38], per-
formed in triplicate.
2.4. Tryptophan ﬂuorescence, blue shift (Δλemi) and acrylamide quenching
The tryptophan ﬂuorescence was monitored using a Varian Cary
Eclipse Fluorimeter (Agilent Technologies, Santa Clara, CA) equipped
with a multicell sample holder and temperature control set to 25 °C.
The peptide (1 μM) in Tris-buffer was excited at 280 nm (slit width
10 nm) and the emission spectra were measured at 300–500 nm (slit
width 10 nm) in the presence or absence of LUVs (100 μM). The differ-
ence in the maximum emission wavelength between the absence and
presence of LUVs is referred to here as the blue shift (Δλemi).
For the acrylamide quenching experiments sequential additions of
5 μl of a 4Macrylamide stock solution (up to 0.15Mﬁnal concentration)
were made to the sample containing the peptide (1 μM) and LUVs
(100 μM). The tryptophan ﬂuorescence was recorded after each addi-
tion of acrylamide and ﬂuorescence intensity changes were analyzed
through Stern–Volmer plots from where the quenching constants
(Ksv) were calculated from the Eq. (1):
Fo=F ¼ 1þ Ksv Q½  ð1Þ
where Fo is the initial ﬂuorescence of the peptide and F is the ﬂuores-
cence following the addition of the quencher Q.
2.5. Circular dichroism (CD) spectroscopy
The secondary structure of the Tritrp1-derived peptides (50 μM)
in buffer (10 mM Tris pH 7.4) and in the presence of SDS micelles
(35 mM) was assessed using a Jasco J-810 spectropolarimeter (Jasco
Inc. Easton, MD). The far-UV spectra were recorded between
190–260 nm in a 1 mm pathlength cuvette at room temperature,
under a constant ﬂow of nitrogen. The ellipticity was registered every
0.1 nm, with a scan rate of 200 nm/min and 0.1 nm bandwidth. The
ﬁnal spectra represent the average of 10 consecutive scans.
2.6. 1H NMR studies and structure determination
For NMR studies peptides (~3 mg) were dissolved in 9:1 H2O:D2O,
and for the peptides interacting with micelles, d25-SDS was added
at 1:100 (peptide:SDS ratio) ensuring a ratio of one peptide molecule
per micelle. A one-dimensional (1D) 1H NMR spectrum was acquired
using 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS) as internal
chemical reference and water suppression was achieved by excitation
sculpting [39]. Two dimensional nuclear Overhauser enhancement
and exchange spectroscopy (NOESY), correlation spectroscopy (COSY)
and total correlation spectroscopy (TOCSY) spectra were obtained for
the peptides with SDS micelles with a mixing time of 0.25 and 0.094 s
for the NOESY and TOCSY experiments respectively. All NMR experi-
ments were acquired on a 600 MHz Bruker Avance spectrometer
(Bruker Corporation, Milton, ON) and were processed with the
NMRPipe software package [40].
The spectral analysis was performed using NMRView 5.2.2.01 [41],
and chemical shift assignments were done according to Wüthrich
[42]. Structural calculations were performed using ARIA 1.2 [43]. Addi-
tionally a manually modiﬁed version of the topology ﬁles in order to in-
clude the 5-hydroxy-tryptophan was used. Broad dihedral restraints
were imposed on all of the non-Gly residues to keep the initial phi and
psi angles within allowable regions of the Ramachandran plot. In the
ﬁnal ARIA calculation run 100 structures were calculated and the 20
lowest energy structures were used for analysis using Procheck [44]
and visualized in MOLMOL [45].2.7. Differential scanning calorimetry (DSC)
The DSC experiments of MLVs and the effects of the Tritrp1-derived
peptides on the thermotropic phase transition were studied using a
Microcal high sensitivity VP-DSC instrument (Malvern Instruments
Inc. Westborough, MA). The ﬁnal concentration of MLVs for each DSC
experiment was 0.5 mg/ml. Five heat scans (10 °C/h), between 20–
60 °C were performed for the experiments involving DPPC and DPPG.
The analysis of the ﬁfth heating scan was performed with the Microcal
Origin Software (version 7.0).
2.8. Calcein leakage
Release of calcein from LUVs was registered by ﬂuorescence spec-
troscopy, which was measured in a Varian Cary Eclipse Fluorimeter
(Agilent Technologies, Santa Clara, CA). Calcein containing LUVs
(10 μM) were incubated in Tris-buffer and the ﬂuorescence was regis-
tered at 520 nm (slit width 10 nm) during 1 min, with excitation at
490nm(slitwidth 10nm). Next the peptidewas added at different con-
centrations and the ﬂuorescence was registered for another 15 min. At
this point all LUVs were solubilized by 0.02% Triton X-100 and the ﬂuo-
rescence registered for anotherminute. The leakage percentagewas cal-
culated according to Eq. (2):
% Calcein leakage ¼ 100 I−Ioð Þ= It−Ioð Þ ð2Þ
where Io is the ﬂuorescence before the addition of the peptide, I is the
ﬂuorescence at 10 min after the addition of the peptide, and It is the
ﬂuorescence after the addition of Triton X-100.
2.9. E. coli outer and inner membrane permeabilization
The peptide-induced permeabilization of the outer and inner mem-
brane in Gram-negative bacteria was recorded as described by Epand
et al. [46]. The method uses the E. coli strain ML35p, which in addition
to being constitutive for cytoplasmic β-galactosidase, also expresses
the plasmid-encoded periplasmic β-lactamase enzyme, and lacks the
lac permease. The membrane impermeable ONPG substrate is hydro-
lyzed by the cytoplasmic β-galactosidase and can be monitored by
absorbance at 420 nm. Similarly, the impermeable NCF is the substrate
of the periplasmic β-lactamase, for which the hydrolysis can be follow-
ed by absorbance at 490 nm.
E. coliML35p was grown at 37 °C in Luria broth (LB) media from a
single colony until OD600 ~ 0.6. The cells were collected and washed
three times with incubation buffer (10 mM Na+-phosphate pH 7.4,
100 mM NaCl and 300 μg/ml LB) and added to a ﬁnal OD600 of 0.3 in
the presence of ONPG (0.5 mM) or NCF (30 μM) in a 96-well plate,
together with peptide concentrations of 0.2 to 20 μM. The absorbance
of thewells wasmeasured at 420 and 490 nm for ONPG andNCF exper-
iments, respectively, every 2 min during 60 min, in a Perkin Elmer
VictorTM X4 Multilabel Plate Reader (Waltham, MA) with shaking and
temperature control at 37 °C.
2.10. DNA mobility/gel retardation assay
In order to evaluate peptide binding to DNA the agarose gel retarda-
tion assay was used [47]. The plasmid DNA pET19b was puriﬁed from
E. coli DH5α cells using the Qiagen Plasmid puriﬁcation kit (Qiagen
Inc. Valencia, CA). The DNA concentration and purity were measured
at A260 and A260/A280 respectively. Plasmid DNA (100 ng)was incubated
at room temperature with increasing amounts of peptides, correspond-
ing to peptide/DNA ratios from 0–10 (w/w), in binding buffer (5% glyc-
erol, 10 mM Tris, 1 mM EDTA, 1 mM DTT, 20 mM KCl, 50 μg/ml BSA,
pH 8.0). After incubation for 1 h, loading dye 5× (10% Ficoll 400,
10 mM Tris, 50 mM EDTA, 0.25% bromophenol blue, pH 7.5) was
added to the mixture and loaded onto a 1% agarose gel in Tris-acetate-
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The gels were run at 100 V for 30 min and its image taken in a Bio-Rad
Geldoc XR (Bio-Rad Laboratories, Hercules CA).
2.11. Macromolecular synthesis inhibition
The inhibition of DNA, RNA and protein synthesis in E. coli was
evaluated using a modiﬁed protocol previously described by Patrzykat
et al. [48]. Brieﬂy, E. coli CGSC 4908 (auxotroph for thymidine, uridine
and L-histidine) was grown overnight at 37 °C from a single colony.
The overnight culturewas diluted 1:103 and grown at 37 °C to the expo-
nential phase (OD600 ~ 0.3). At this point the cells were collected and
resuspended in M9 minimal media [49], to OD600 0.3. Aliquots
(300 μl) of the cell suspensions were supplementedwith 9 μl of either
[3H]-thymidine, [3H]-uridine or [3H]-L-histidine and 100 mg/l of the
other two unlabeled precursors. After 5 minutes incubation at 37 °C
peptides were added at speciﬁc concentrations (0, 0.8, 2, 4 and 8 μM),
followed by incubation for 30 more minutes at 37 °C. At time points
of 0, 5, 15 and 30 min 50 μl samples were taken from the cultures and
incubated in 5 ml 10% trichloroacetic acid (TCA) supplemented with
200 mg/l of all three unlabeled precursors for 40 min on ice, followed
by 15min incubation at 37 °C. The DNA, RNA and proteinswere collect-
ed over vacuum using 25 mm nucleic acid and proteins transfer ﬁlters
from Whatman GmbH (Dassel, Germany). The ﬁlters were rinsed 10
times with cold 10% TCA and dried at 70 °C. Each ﬁlter was placed in a
scintillation vial with 10 ml of BCS-NA non-aqueous biodegradable
counting scintillant (GE Healthcare, Piscataway, NJ) and the radioactive
counts recorded for 1min in a Beckman LS6500multi-purpose scintilla-
tion counter (Beckman Coulter, Brea, CA).
In order to establish how these peptide concentrations affect the
growth of E. coli CGSC 4908, a separate growth assay was performed.
The bacterial cells were prepared as described before in M9 minimal
media supplemented with 200 mg/l of all three unlabeled precursors
and incubated at 37 °C. At each time point, samples of 5 μl were diluted
1:4 × 104 in water and 100 μl plated in LB-agar plates. After incubation
overnight at 37 °C, the number of colonies was counted.
3. Results
3.1. Antibacterial activity
The MIC and MBC activities of the Tritrp1-derived peptides are pre-
sented in Table 2. All peptides exhibited a higher antimicrobial activity
towards the Gram-positive organism B. subtilis 168 in comparison to
the Gram-negative E. coli ATCC 25922. In addition, the antibacterial
activity of all peptides after 18 h was shown to be bactericidal rather
than bacteriostatic, as indicated by the similar MIC and MBC values.
The peptide Tritrp1 had aMIC of 4 μMagainst E. coli, which corresponds
well to previously reported data [16,20]. ThisMIC valuewas comparable
to the 2–4 μM obtained for melittin, a known strong membrane-lytic
peptide [50]. Individual or triple substitutions of Trp residues by
5OHW did not have any large effects on the antimicrobial activity of
the Tritrp1 analogs.Table 2
Antimicrobial activities of Tritrp1-derived peptides and melittin reported as minimal
inhibitory and bactericidal concentrations (μM), MIC and MBC respectively.
E. coli ATCC 25922 B. subtilis 168
MIC MBC MIC MBC
Tritrp1 4 4 1 1
HW 4–8 4–8 0.5–1 0.5–1
HW1 4–8 4–8 2 2
HW2 8 8 1 1
HW3 4–8 4–8 1 1
Melittin 2–4 2–4 0.25–0.5 0.25–0.5
The values presented are the results of three independent experiments.3.2. Tryptophan ﬂuorescence spectroscopy and blue shift measurements
The ﬂuorescence excitation and emission spectra for Tritrp1 and its
derived peptides in buffer are depicted in supplementary Fig. S1,
while the maxima wavelengths obtained from these spectra are pre-
sented in Table 3. Tritrp1 exhibited a ﬂuorescence emission maximum
at 349 nm, while the excitation maximum was located at 280 nm.
These values are characteristic for Trp in a polar environment (supple-
mentary Fig. S2). In comparison, the peptidewith three 5OHW residues
(HW) showed an excitation maximum wavelength at 311 nm, which
correspond to the 310 nm shoulder observed for 5OHW amino acid in
buffer (supplementary Fig. S2). However, the emission maximum of
HW located at 398 nm represents an extremely red shifted emission
in comparison to the maximum for the 5OHW in buffer located at
340 nm (supplementary Fig. S2). For the individually substituted pep-
tides (HW1, HW2 and HW3) in buffer the excitation and emissionmax-
ima wavelength were similar, located around 280 and 338 nm
respectively.
The ﬂuorescence emission spectrum of the Trp side chain is highly
sensitive to the polarity of the environment, and its maximum wave-
length (λemi, max) can be used to study the interactions between Trp-
containing peptides and membranes. During peptide–membrane inter-
actions, the exposure to a more hydrophobic environment induces a
decrease in the λemi, max of the Trp side chain, which is known as blue
shift. In comparison to Trp, the 5OHW side chain is less sensitive to sol-
vent polarity changes, thus limiting the usefulness of 5OHW as a probe
for studying peptide–membrane interactions [51]. The ﬂuorescence
maxima wavelength and the blue shift for all Tritrp1-derived peptides
upon interaction with membranes are shown in Table 3 and supple-
mentary Fig. S1. Tritrp1 exhibited a large blue shift (12 nm) in the pres-
ence of ePC:ePG vesicles,while a smaller blue shift (5 nm)was observed
with ePC:Chol vesicles. In contrast, the HW peptide exhibited a similar,
although small, blue shift for both ePC:ePG and ePC:Chol vesicles. In the
case of single substituted peptides, no differences were observed
between the presence of ePC:ePG and ePC:Chol vesicles. Both vesicles in-
duced only a minor blue shift (0–2 nm).
3.3. Acrylamide quenching
Complementary to the ﬂuorescence blue shift experiments, solvent
accessibility measurements of the Trp side chain can provide information
about the peptides environment when in buffer or in the presence of
membranes. Acrylamide quenches the ﬂuorescence of solvent exposed
Trp residues. Its uncharged nature allows quenching studies involving
negatively charged membranes, which can inﬂuence the behavior of
ionic quenchers such as Cs+ and I− [52]. Both amino acids Trp and
5OHWare similarly quenchedby acrylamide as shown in the supplemen-
tary Fig. S3. The acrylamide quenching levels (represented by Ksv) for the
Tritrp1-derived peptides in buffer or in the presence of lipid vesicles are
presented in Fig. 1. The ePC:ePGvesicles exhibit a net negatively charged
surface resembling bacterial cell membranes, while the use of a zwitter-
ionic phospholipid (PC) and cholesterol simulated the electrically neu-
tral and ﬂuidity/rigidity characteristics of a eukaryotic membrane. AllTable 3
Maximum ﬂuorescence excitation (λexc, max) and emission (λemi, max) wavelengths (nm)
for the Tritrp1-derived peptides in Tris-buffer and blue shift (Δλemi a) upon binding to
LUVs. Blue shift results are average ± S.D. (n = 3).
Tris-buffer Blue shift
λexc, max λemi, max ePC:ePG ePC:Chol
Tritrp1 280 349 12 ± 1 5 ± 2
HW 311 398 4 ± 2 1 ± 4
HW1 280 337 0 ± 1 1 ± 0
HW2 278 338 1 ± 1 1 ± 0
HW3 280 339 2 ± 1 1 ± 0
a Δλemi = λemi, max (buffer) − λemi, max (LUVs).
0 
20 
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60 
80 
Tritrp-1 HW HW1 HW2 HW3 
K
sv
 
Fig. 1. Stern–Volmer constants (Ksv) for the Tritrp1-derived peptides as determined from
the acrylamide quenching experiments in different media: buffer (white), in the presence
of ePC:ePG LUVs (black) and ePC:cholesterol LUVs (dotted). Results are average ± S.D. (n =
3).
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exhibiting small Ksv values in comparison to those observed in buffer.
In contrast, higher Ksv values were observed in the presence of ePC:
Chol vesicles. Interestingly the Ksv of HW in buffer was considerably
lower than all other peptides, indicating that this peptide has unique
properties.
3.4. Circular dichroism spectroscopy
The far-UV CD spectra of the Tritrp1-derived peptides in buffer and
in SDS micelles are presented in Fig. 2. These micelles were selected in
order to simulate the negative surface charge of bacterial membranes.
According to the appearance of the CD spectra, the peptides could be
divided in two groups. The ﬁrst group was formed by Tritrp1, HW1-150 
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Fig. 2. Circular dichroism far-UV spectra of Tritrp1-derived peptides in aqueous environ-
ment (solid) and SDS micelles (dashed). The experiments were performed in duplicate,
representative results are shown.and HW3. Their CD proﬁle was dominated by a strong negative band
around 226 nm. Upon interaction with SDS micelles the intensity of
this negative band was slightly modiﬁed, while two positive bands at
207 and 195 nm appeared for Tritrp1 and HW1. The second group
was formed by HW and HW2. In buffer HW exhibited two negative
bands, a strong band around 205 nm and a weaker band at 230 nm.
The presence of SDS micelles only modiﬁed the CD signal at 190 nm.
HW2 showed weak signals in buffer with negative peaks at 200 and
228 nm. However a considerable conformational change was observed
in the presence of SDS micelles due to the presence of negative bands
at 190 and 215 nm. These data conﬁrm that all peptides bind to these
membrane mimetics.
3.5. 1H NMR studies and structure determination
In addition to the secondary structural information obtained by cir-
cular dichroism, 1D and 2D 1H NMR spectroscopy were used to study
in detail the 3D-structures induced by the binding of the Tritrp1-
derived peptides to the SDS micelles (Fig. 3). 1H NMR studies of Tritrp1
inDPC and SDSmicelles have already been reported [17], hence only the
5OHW containing peptides were analyzed. In buffer the peptides HW1,
HW2 and HW3 exhibited at least nine resonances in the spectral region
corresponding to the Hε1 of the Trp residues (9.0–11.0 ppm). The pres-
ence ofmore than three peaks, corresponding to the indole-NH group of
the three Trp residues in tritrpticins, is an indication of multiple confor-
mations co-existing in aqueous solution as described previously [16].
Upon binding to micelles three main signals were clearly dominating
the NMR spectra for the single substituted peptides. This indicates that
the interaction among the peptides and the micelles favors the forma-
tion of a single more stable conformation. For HW, only three reso-
nances were observed in buffer and in the presence of SDS micelles,Fig. 3. One-dimensional proton NMR spectra for the Hε1-tryptophan region of Tritrp1-
derived peptides in Tris-buffer (left) and in the presence of d25-SDS micelles (right) at
37 °C.
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both cases. However, the peak intensities in micelles were reduced,
as their linewidths increased, compared to the spectra for the other
peptides.
The 3D-structure for the main micelle-bound conformation of the
peptides was established by 2D 1H NMR experiments. The structures
determined for the single substituted peptides HW1, HW2 and HW3
are depicted in Fig. 4. The structural statistics are provided in the supple-
mentary data (supplementary Table S1). The structure of HW1 in the
presence of SDS micelles resembled the elongated boat-like structure
reported previously for tritrpticin in DPC micelles [16]. A clear amphi-
pathic conﬁguration emerged from the spatial separation of the polar
Arg residues located in the N- and C-terminal regions. These regions
faced one side of the molecule, while the hydrophobic core formed by
the Trp residues was facing the other side (Fig. 4). In comparison
to HW1, HW2 and HW3 exhibited a more compact structure. Both N-
and C-terminal regions are located closer to each other, and in the
case of HW3 this behavior was even more pronounced. This conforma-
tion allows for amore extreme amphipathic structure as depicted in the
electrostatic surface charge distribution (Fig. 4).
3.6. Differential scanning calorimetry
DSC of membrane models using DPPG and DPPC phospholipids was
performed to study how the peptide–membrane interactions affect the
lipid packing in MLVs (Fig. 5). DPPC and DPPG are normally used to
emulate different biologicalmembranes. DPPG has a negatively charged
head group, which simulates the negative charge observed on the bac-
terial membrane surfaces. Similarly DPPC is a zwitterionic phospholipid
that can be used to simulate the neutral charge of the outer leaﬂet of
eukaryotic membranes [53].
The DPPC lipids exhibited a main phase transition peak at 41.2 °C
and a pre-transition peak located at 34.2 °C. Upon binding to DPPC
lipids, all peptides modiﬁed the pre-transition peak, but the changes
in the main transition temperature (Tm) were restricted to +/− 0.1 °C
(Fig. 5A). In contrast there was a stronger inﬂuence on the lipid pack-
ing in DPPG membranes upon interaction with the Tritrp1 and the
5OHW containing peptides (Fig. 5B). DPPG lipids exhibited a mainFig. 4. Solution structures of single substituted Tritrp1-derived peptides (HW1, HW2 and
HW3) in d25-SDS micelles. Overlays of the 20 lowest energy structures (left), ribbon rep-
resentation of the backbone and tryptophan residues (middle) and electrostatic potential
surfaces (right) were depicted using the software package MolMol. The structures are
overlaid for the backbone atoms 4–11, with RMSDs of 0.096, 0.256 and 0.200 Å, for
HW1, HW2 and HW3 respectively.phase transition peak at 40.0 °C, with a pre-transition peak located at
29.8 °C. The pre-transition peak in all cases also disappeared (Fig. 5B),
and the Tm of the main transition was maintained between 39.7 °C
and 41.2 °C. However, there was a considerable broadening of the
main transition peak accompanied by the appearance of shoulders or
smaller peaks at lower temperatures. The latter probably represent
the formation of peptide–lipid clusters.
3.7. Calcein leakage
The ability of the peptides to induce membrane permeabilization
was assessed by the calcein leakage method in both ePC:ePG and ePC:
Chol LUVs (Fig. 6). Tritrp1 was able to induce substantial leakage of
entrapped calcein from ePC:ePG (Fig. 6A) and ePC:Chol (Fig. 6B) vesi-
cles, as previously described [16,20]. In contrast to Tritrp1, when calcein
containing ePC:ePG and ePC:Chol vesicles were incubated with the HW
peptide almost no calcein leakage was observed (Fig. 6). The individual
modiﬁcations of the three Trp residues indicated that the location of the
substituted residues determine the effect on the permeabilization of the
ePC:ePG membrane (Fig. 6A). HW2 and HW3 exhibited a similar, or
even slightly higher tendency to induce calcein leakage than Tritrp1,
while HW1 induces calcein leakage at an intermediate level between
Tritrp1 and HW. In contrast all three individually substituted peptides
(HW1, HW2 and HW3) exhibited a similar intermediate level of calcein
leakage in ePC:Chol vesicles (Fig. 6B).
3.8. E. coli outer and inner membrane permeabilization
Membranemimetic systems such as LUVs only allow the simulation
of particular characteristics of biological membranes, as they obviously
cannot fully represent the highly complex and heterogeneous bacterial
membrane. In order to visualize the effect of our Tritrp1-peptides in a
more biologically relevant system, the E. coli ML35p bacterial strain
was used, and permeabilization of its inner and outer membrane was
studied by following ONPG and NCF hydrolysis [46].
The inner membrane permeabilization induced by all peptides is
shown in Fig. 7 (left). Tritrp1 (4 μM) clearly induced a considerable
increase in the membrane permeabilization, as detected by a fast rate
of ONPG hydrolysis by β-galactosidase, with a lag period of 10 min.
This peptide concentration corresponds to the MIC value against E. coli
ML35p (data not shown). In contrast, triple substitution of the Trp res-
idues by 5OHW completely abolished the inner membrane perme-
abilization even at a concentration of 20 μM. Individually substituted
peptides (HW1, HW2 and HW3) exhibited a similar behavior among
them. All three peptides induced membrane permeabilization at con-
centrations of 4 and 8 μMwith a time lag period of 20–40 min.
The outer membrane permeabilization induced by Tritrp1 and its
derived peptides is shown in Fig. 7 (right). All peptides seemed to in-
duce similar levels of outer membrane permeabilization allowing NCF
to reach the periplasmic β-lactamase and hydrolysis to take place
(Fig. 7, right). However it is important to note that even in the absence
of peptides there was a basal level of NCF leakage and hydrolysis, corre-
sponding to a steady increase in the absorbance at 490nm.Nevertheless
it was still possible to observe differences in the permeabilizing abil-
ity of the peptides tested. Tritrp1 and HWwere the strongest permea-
bilizing agents for the outer membrane. A concentration of 0.8 μMwas
sufﬁcient to induce a rapid increase in the absorbance over the basal
level. The peptides HW1, HW2 and HW3 exhibited again a similar
behavior when compared to each other, inducing permeabilization
only at 2 μM or higher concentrations.
3.9. Macromolecular synthesis inhibition
The inhibition of vital intracellular processes such as DNA-, RNA- and
protein syntheses due to the action of Tritrp1 and the triple substituted
HW peptide are presented in Fig. 8. Only Tritrp1 and HWwere studied
Fig. 5. Differential scanning calorimetry scans of DPPC (A) and DPPG (B) MLVs interacting with Tritrp1-derived peptides at 1:10 (peptide:lipid) molar ratio. Enhancements of the main
phase transition for DPPG in the absence or presence of peptides are also depicted in supplementary Fig. S4.
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teraction and permeabilization. In contrast, the behavior of HW1, HW2
and HW3 was similar to Tritrp1, as detected in the earlier experiments.
Tritrp1 was able to induce complete inhibition of the synthesis of
DNA, RNA and proteins, at peptide concentrations as low as 0.8 μM, cor-
responding to 1/5 of theMIC value for E. coliATCC 25922. This inhibitory
effect was efﬁcient, considering that in the ﬁrst 5 min of incubation
complete inhibition was observed (Fig. 8A, C and E). Higher concentra-
tions of the HWpeptide (2 μM) were required in order to achieve com-
plete inhibition of the DNA, RNA and protein synthesis comparable to
Tritrp1 (Fig. 8B, D and F). It is important to note that the peptide concen-
trations used in this experiment did not induce complete cell death over
the time frame of these experiments (data not shown).0 
20 
40 
60 
80 
100 
0 0.02 0.04 0.06 0.08 0.1
Le
ak
ag
e 
%
 
Peptide/Lipid 
0 
20 
40 
60 
80 
100 
0 0.02 0.04 0.06 0.08 0.1
Le
ak
ag
e 
%
 
Peptide/Lipid 
A
B
Fig. 6. Calcein leakage percentage for the Tritrp1-derived peptides in the presence of ePC:
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Tritrp1 (solid, ♦), HW (solid, ■), HW1 (dashed, ▲), HW2 (dashed, ●) and HW3 (dashed,
−). Results are average ± S.D. (n = 3).3.10. DNA mobility/retardation assay
Considering that the bacterial membrane might not be the only
target of Tritrp1, intracellular DNA has been proposed as a possible
antimicrobial targets for some cationic antimicrobial peptides [12,13].
It is expected that due to the cationic nature of Tritrp1 and its deriva-
tives (+5), they are attracted to highly negatively charged molecules
such as DNA. The peptide–DNA interactions were studied by following
the changes in DNA mobility during agarose electrophoresis. Binding
of a peptide to DNA will considerably increase the size of the molecule,
affecting or even preventing itsmobility through the agarose gel (Fig. 9).
We observed, that Tritrp1was the strongest DNA binder among all pep-
tides; addition of only 200 ng was enough to completely inhibit DNA
mobility. The substitution of all Trp for 5OHW residues considerably
affected the interaction of the peptides with DNA as shown by the higher
HW concentrations required to inhibit DNAmigration in the agarose gel.
For the individually substituted peptides the location of the Trp substitu-
tion inﬂuenced the DNA binding ability of the peptide. HW1 was highly
affected, while HW2 and HW3 bound somewhat stronger to the plasmid
DNA.
4. Discussion
Numerous studies of AMPs have focused on attempts to improve
their microbicidal activity by substitution or modiﬁcation of amino
acid residues, while simultaneously enhancing their selectivity for pro-
karyote cells. In the case of tritrpticin and its C-terminally amidated
version Tritrp1, the Trp, Arg and Pro residues have been shown to be im-
portant for the antimicrobial activity [16–21]. Mutated versions of
Tritrp1 with Tyr and Phe residues replacing all three Trp revealed only
small changes in microbicidal activity [16,18]. A similar result was ob-
tained in this study, indicating that the addition of a hydroxyl group to
the indole ring on all three Trp residues of Tritrp1 did not alter the pep-
tide concentration required to kill E. coli cells. However MIC and MBC
experiments cannot account directly for any changes in themechanism
of action that may accompany these modiﬁcations of the indole rings.
The bacterial membrane is one of the ﬁrst barriers that govern the
action of any AMP. Hence our work focused mostly on studying the
interactions between the Tritrp1-derived peptides and different model
membranes. Clearly these interactions are dominated by electrostatic
interactions, as indicated by the preference for model membranes
with negatively charged rather than neutral zwitterionic phospholipids
headgroups. This behavior was also reﬂected by the larger ﬂuorescence
blue shifts and the smaller Ksv when binding to ePC:ePG in comparison
to ePC:Chol vesicles, for the triple substituted (HW)peptide and Tritrp1.
In spite of being less sensitive to the polarity of the environment [35,51],
the 5OHW substituted peptide could still be used to conﬁrm the
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Fig. 7. Permeabilization of inner (left) and outer (right) membranes of E. coliML 35p induced by the Tritrp1-derived peptides. Absorbance at 420 and 490 nm registered ONPG and NCF hydro-
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Fig. 8. Inhibition of the macromolecular synthesis of DNA (A, B), RNA (C, D) and proteins (E, F) induced Tritrp1 (left) and HW (right). Peptide concentrations were as follows: 8.0 (●), 4.0
(▲), 2.0 (■), 0.8 (□) and 0 µM (◆). The antibiotics (×) ciproﬂoxacin 1 µg/ml, rifampin 32 µg/ml and chloramphenicol 16 µg/mlwere used as reference for DNA, RNA and protein synthesis
inhibition, respectively. The experiments were performed in duplicate, representative results are shown.
285M. Arias et al. / Biochimica et Biophysica Acta 1848 (2015) 277–288interaction between HW and membranes (Table 3). However for all
three individually substituted peptides (HW1, HW2 and HW3) the
combined ﬂuorescence maximum for Trp and 5OHW in buffer was
close to 340 nm, indicating a more hydrophobic environment for the
Trp residues. This characteristic of HW1, HW2 and HW3 precluded the
use of blue shift as a reliable indicator of peptide-membrane interac-
tions. Nevertheless acrylamide quenching experiments were successfulFig. 9. Binding of Tritrp1-derived peptides and melittin to plasmid DNA (pET-19b) evaluated th
experiments were performed in triplicate, representative results are shown.in conﬁrming the preference for negatively chargedmembranes for the
bound peptides (Fig. 1). In addition to the ﬂuorescence spectroscopy
results, our DSC measurements also indicated a strong perturbation of
the DPPG lipid packing induced by the interaction with all the 5OHW-
containing peptides. Such perturbations were minimal in the presence
of zwitterionic DPPC membranes (Fig. 5). A similar preference for
model membranes with negatively charged phospholipid headgroupse by the gel retardation assay. Peptide to DNA ratios (w/w) between 0–10 were used. The
286 M. Arias et al. / Biochimica et Biophysica Acta 1848 (2015) 277–288was also exhibited by tritrpticin and several analogs when binding to
DMPC and DMPG vesicles [54].
The binding of AMPs tomembranes usually induces a conformation-
al change in the peptide, which is believed to be important for their
antimicrobial activity [55,56]. In thiswork all the single substituted pep-
tides (HW1, HW2 and HW3) acquired different conformations upon
binding to SDS micelles, as indicated by changes in their CD proﬁle
(Fig. 2). However the assignment of a speciﬁc secondary structure to
these spectra is limited by the high content of aromatic residues that
contribute to a strong band close to 230 nm. This band has been attrib-
uted to the interaction of Trp residues with the backbone of the peptide
and stacking of these residues [57]. Furthermore the possibility of a
heterogeneous population of conformers also restricts the interpreta-
tion of the CD spectra, providing only an average of all the different con-
formers co-existing in a particular case. Surprisingly, the CD spectra of
the HW peptide did not undergo considerable changes when adding
SDS micelles, suggesting that the structure of the peptide is not highly
modiﬁed in this environment, or that it does not bind tightly to these
micelles.
To obtainmore detailed information about the possibility ofmultiple
bound peptide conformations, 1D 1H NMR spectroscopy was used
(Fig. 3). The presence of the Trp and 5OHW residues allowed inspection
of the spectral region between 11.0 and 9.0 ppm, where only the Hε1
protons of the indole rings are detected. This portion of the 1H NMR
spectra is far removed from the highly crowded 9.0–5.0 ppm region,
where most of the aromatic and amide proton resonances are located.
In all 5OHW containing peptides, except for HW, the change from an
aqueous environment to the SDSmicelles was accompanied by a reduc-
tion from several structural conformers to one major conformation.
Similar results were previously reported for tritrpticin and some of its
analogs [16,47]. The presence of multiple structural conformers is likely
related to the cis-trans isomerization of the two Pro residues in the par-
ent peptide [16,17]. Interestingly again, the HW peptide displayed a
unique behavior as it exhibited one main conformation in aqueous
environment as well as in the presence of SDS micelles. This phe-
nomenon might be explained by inter- and/or intra-molecular inter-
actions among the 5OHW residues, stabilizing the peptide's structure.
Inter-molecular interactions would generate peptide dimers or oligo-
mers, while intra-molecular interactions would create a more stable/
structured peptide. The notion that such interactions occur for HW is
also supported by the low efﬁciency of acrylamide quenching and the
extraordinary red shifted ﬂuorescence of the HW peptide (λem, max
398 nm) observed in aqueous environment.1
In order to establish the detailed 3D structures of the peptides when
bound to micelles, 2D 1H NMR experiments were performed. However
only the single substituted peptides could be analyzed and their struc-
ture calculated. The NMR spectra for HW proved to be very challenging
due to lowpeak intensities and peak overlap, precluding the satisfactory
assignment of theNMR resonances. HW1preserved the turn-turn struc-
ture that is characteristic for its parent peptide tritrpticin bound to SDS
micelles [17], and for Tritrp1 associated with DPC micelles [16]. In con-
trast, HW2 and HW3 diverged from this structural arrangement,
exhibiting less extended structures with a more compact distribution
of their hydrophobic residues. HW2 conserved one of the β-turns
involving Pro-5, while HW3 did not exhibit any obvious β-turns. These
changes allowed for a closer proximity between the N- and C-terminal
regions of the peptides, generating a more compact amphipathic mole-
cule. The formation of these amphipathic structures is in agreement
with the strong interactions between the peptides and model mem-
branes revealed by the previously discussed biophysical techniques.
We note with interest that in spite of the different micelle-bound 3D-
structures, these three peptides display essentially the same antimicrobi-
al activity, indicating that the differences in the backbone conformation1 In our laboratory similar red shiftedﬂuorescencemaximahave beenobserved in other
Trp-rich antimicrobial peptides that were substituted with multiple 5OHW.per se do not dictate the activity. Rather a more general amphipathic
structural fold seems to be mainly responsible [5].
The mechanism of action of Tritrp1 has been related to its ability to
induce membrane permeabilization, as observed by calcein leakage in
different membrane mimetic systems [16,21]. In this study the three
single substituted Tritrp1-derived peptides were also able to induce
calcein leakage from zwitterionic and negatively charged vesicles. Inter-
estingly, the Trp indole ring at position six wasmost important for pro-
moting leakage by Tritrp1 in ePC:ePG vesicles, as shown by the decrease
in calcein leakage in HW1. Calcein leakagewas not observed uponmod-
iﬁcation of all three Trp residues in the HWpeptide. These results are in
agreement with the lack of permeabilization induced by Tritrp1 analogs
were all Trp residues were replaced by Tyr or Phe residues [16,18].
Although these results suggest that membrane permeabilization might
no longer be the main mechanism of action of the HW peptide, the
fact that a very simple membrane mimetic LUV system was used pre-
cludes the conﬁdent extrapolation of this notion to the case of bacterial
membranes [58].
In order to evaluate permeabilization in a more realistic in-vivo set-
ting, actual bacterial cells (E. coli) were used. One important aspect of
this experiment [46], is thatmembrane permeabilization can be divided
into two steps, perturbation of the outer and inner membranes. The
outer membrane is sometimes overlooked in mechanistic studies of
AMPs, when only model membrane systems are used. However in sev-
eral studies this barrier has been shown to modify the susceptibility of
Gram-negative bacteria to some AMPs [58–60]. The inner membrane
permeabilization experiments revealed a consistent behavior with the
calcein leakage experiments. Tritrp1 and the single substituted peptides
were able to induce inner membrane permeabilization, while HWwas
unable to permeabilize the cytoplasmic membrane of E. coli even at a
concentration of 5× MIC. Interestingly, the outer membrane revealed
a different behavior. As expected all peptides that induced inner mem-
branepermeabilization also induced outermembrane permeabilization.
Nevertheless, the inner membrane-inactive HW peptide could induce
an increase in outer membrane permeabilization similar to Tritrp1
and the other analogs studied here. These results identiﬁed the outer
membrane of E. coli as a main target for HW. At the same time we can
conclude that Tritrp1's antimicrobial activity does not arise only from
the perturbation of the inner membrane but also from disruptions of
the E. coli outer membrane.
The strong ability of Tritrp1 to permeabilize the E. coli cytoplasmic
membrane likely induces a complete collapse of many bacterial func-
tions, due to the destruction of the electro-chemical gradient across
the membrane. In this scenario, energy-dependent processes such as
DNA, RNA and protein synthesis would also be completely inhibited.
In thiswork Tritrp1 simultaneously inhibited the incorporation of radio-
actively labeled precursors for DNA, RNA and protein, when E. coli cells
were exposed to sub-lethal concentrations of the peptide. In addition
the strong afﬁnity of Tritrp1 for plasmid DNA (Fig. 9), indicated that if
Tritrp1 is able to reach the cytoplasm of the bacteria, following the per-
meabilization of the inner membrane, the interaction with the chromo-
somal DNA would likely directly inhibit the macromolecular synthesis
as well.
HWon the other handwas also capable of simultaneously inhibiting
the synthesis of DNA, RNA and proteins, although the processwasmuch
slower and higher peptide concentrations were required (Fig. 8). In
combination with the lack of inner membrane permeabilization, these
results suggest that the substitution of all three Trp residues by 5OHW
in Tritrp1 modiﬁed the mechanism of action of the peptide. It suggest
that HW, similar to Tritrp1, can gain access to the periplasm through
the “self-promoted uptake”mechanism [61]. However, once in contact
with the inner membrane a non-permeabilizing membrane transloca-
tion process might take place, releasing HW into the cytoplasm where
it encounters different intracellular targets. HW can indeed bind to
plasmid DNA and partially inhibit its migration through the agarose
gel, suggesting that DNA could be one of HW's intracellular targets.
287M. Arias et al. / Biochimica et Biophysica Acta 1848 (2015) 277–288Nevertheless, it is important to stress that the inter- or intra-molecular
interactions of HW in solution will likely modify its interactions with
other peptide, membranes and DNA. Be that as it may our data shows
that multiple 5OHW substitutions had a profound effect on the mecha-
nism of action of Tritrp1.
5. Conclusions
In conclusion it was possible to identify that changes in the peptide–
lipid interactionswere induced by the substitution of all Trp residues by
5OHW in Tritrp1. These changes led to a differentmechanismof antimi-
crobial activity in the case of Gram-negative bacteria, which did not
involve the permeabilization of the cytoplasmic membrane. The interac-
tion and perturbation of the outer membrane was the only membrane-
related effect observed for the HW peptide. The antimicrobial activity
of HW could be the result of direct perturbation of the outer membrane
leading to cell arrest and consequently to death. However it is also possi-
ble that the peptide, similar to buforin II [62], translocates through the
cytoplasmic membrane without affecting the membrane permeability.
Once in the cytoplasm, interactions with intracellular targets would
then inhibit the synthesis of macromolecules (DNA, RNA and protein),
resulting in bacteria death. Additionally in our work the importance of
the cluster of three Trp residues in the tritrpticin core was conﬁrmed.
Moreover the use of 5OHW as Trp substitutes proved to be useful in
order to study the mechanism of action of Trp-rich AMPs. Furthermore
we have demonstrated that 5OHWcan also beused as a new amino acid
analog to modulate the antimicrobial activity and mechanism of action
of other Trp-rich antimicrobial peptides.
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